Bharat Biotech's covacin vaccine will be approved by the World Health Organization on October 5


1,57,925 new corona cases and deaths in the U.S. 1938

The total number of corona cases in the world was 2,28,58,749 and the total death toll was 46,95,798.

Corona's antibody treatment called Ronapriv was approved in the UK

In the US, the FDA will allow booster doses for people over 65

WASHINGTON: The total number of corona cases rose to 228,587,449 with more than two million new corona cases reported worldwide, while the total death toll from corona rose to 46,95,798 with 3,447 deaths. There were 1,57,925 new cases of corona reported in the USA yesterday and 1938 deaths.

The total number of corona cases in the USA is 42,800,494 while the death toll is 6,90,715. Among the countries where more than 5 million cases of corona have been reported are USA 42,799,907, India 33,417,390, Brazil 21,102,536, UK 74,00,739, Russia 72,54,754, France 70,29,959, Turkey 67,94,700, IRNA 37,159.

Among the countries with a total corona death toll of more than 1.5 million are USA 6,90,715, Brazil 5,89,744, India 4,44,563, Mexico 2,70,538, Peru 1,98,948, Russia 1,97,425, Indonesia 1,40,323, UK 1,35,312. , Italy 1,30,284 and Colombia 1,25,826. Meanwhile, the World Health Organisation's decision to allow the corona vaccine covacin, developed by Bharat Biotech in Hyderabad, to be used in emergencies is likely to be delayed until October 5.

A meeting of the Strategic Advisory Group of Experts on Immunization-Sage, which approves the World Health Organization's covacin, will be held on October 5. Sage member Hanna Nohinek said the meeting would also present clinical data from the first, second and third trials of Kovacin, as well as post-marketing studies on safety, immunogenicity, EFC and effectiveness, on the basis of which Sage would recommend its approval.

According to Bharat Biotech, clinical trial data of covacin has been collected and is available from June 2021. This data has been submitted for approval in early July. As the responsible vaccine manufacturer for other vaccines, we do not wish to comment on the approval process or the time it takes.

The covacin vaccine has been developed by Hyderabad-based company Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology. In the USA, meanwhile, the FDA has decided to give booster doses to people over the age of 65, six months after receiving both doses of the Pfizer-Bioentech corona vaccine.

Meanwhile, UK Health Minister Sajid Javed announced that antibody treatment called Ronapriv would be available in UK hospitals from next week. Former US President Donald Trump was given an antibody treatment called Ronapriv when he contracted the corona last year. Initially, those who have not developed an antibody response to the corona virus will be given a combination of two monoclonal antibodies, Ronapriv.

Ronapriv is the first antibody medicine specifically designed to treat corona that has been approved by the Medicines and Healthcare Products Regulatory Agency for use in the UK. The National Health Service has also started antibody treatments called Tosilizumab and Serilumab. Corona's patient is admitted to the ICU and given this treatment within 24 hours, the risk of death is reduced by 24%.

Comments